For The Better

The biotech’s diversification efforts continue.

The fundamentals say boom. The stock price says the boom is ending. One of them is wrong.

Amazon has a large stake in Anthropic.

Oil may not be the big driver of stocks that it was a few months ago — and the market’s pullback may simply be a healthy breather for hot stocks.

Why opt for speculation when you could grab a 6.3% dividend yield that’s been paid for 127 years in a row?

Despite churning out incredible numbers, semiconductor stocks still seem to somehow “miss expectations.” The team digs into Wall Street’s expectations game.

J&J has more than 28 sources of blockbuster revenue.

Maybe you should, too.

The rocket maker’s slide has come with almost no insider supply hitting the market. That changes within weeks.

Every so often, five quotations come along that don’t merely make you nod. They make you stop, put the book down, and think.

Netflix shares sank yet again after it reported its second-quarter results.

AMD looks like a buy ahead of its Advancing AI event.

As countries around the world drastically expand nuclear energy capacity, these two stocks could be huge winners.

The search giant promised its most powerful AI model in June. It’s still not here.

It’s time for the next installment of the 2026 Financial Planning Challenge, focusing on retirement.

They can help stabilize your portfolio in these otherwise volatile times.